Variations of Cortisol Hydroxylation and Paracetamol Metabolism in Patients with Bladder Carcinoma
Authors:
- 21 November 1988
- journal article
- research article
- Published by Wiley in British Journal of Urology
- Vol. 62 (5) , 419-426
Abstract
Summary— We investigated the possibility that variations of the metabolism of xenobiotic compounds might be involved in the process of bladder carcinogenesis, by studying activation reactions (phase I) and detoxification reactions (phase II) of xenobiotic compounds in a group of patients with transitional cell carcinoma of the bladder and in a group of controls hospitalised with other diseases. As an indirect estimate of activating reactions (phase I) we measured Cortisol hydroxylation, expressed as the ratio between urinary 6‐beta‐OH‐Cortisol and 17‐OH‐corticosteroids. Cortisol hydroxylation was not increased in the group of patients when compared with controls. The variations of phase II conjugating enzymes were followed indirectly by administering paracetamol and measuring the urinary excretion of its main metabolites over a period of 12 h. The variations in the metabolic conjugation of paracetamol were expressed as a percentage of each metabolite, or of unmodified paracetamol excreted in the urine, or as the ratio between a given metabolite and unmodified paracetamol. The data were analysed with a logistic regression model, analysing the effects of possible confounding variables such as age, smoking, alcohol, blood nitrogen, blood creatinine, glutamic‐pyruvic (SGPT), glutamic‐oxalacetic transaminases (SGOT) and percent recovery of paracetamol in the urine. Statistical analysis showed that the excretion of mercapturate derivatives of paracetamol was significantly increased in the group of patients. The levels of glucuronic, sulphate and cysteine metabolites were not varied significantly. Since mercapturate derivatives are formed as a consequence of the formation of short‐lived metabolites of paracetamol which react with protein, nucleic acids or glutathione, the increased excretion of mercapturic acid derivatives in cancer patients might be an indication of a higher capability of forming reactive molecular species from xenobiotic compounds. We suggest that this factor might play a role in the induction of bladder cancer.Keywords
This publication has 35 references indexed in Scilit:
- Metabolic oxidation phenotypes as markers for susceptibility to lung cancerNature, 1984
- Carcinogens, Drugs, and Cytochromes P-450New England Journal of Medicine, 1983
- ROLE OF N-ACETYLTRANSFERASE PHENOTYPES IN BLADDER CARCINOGENESIS: A PHARMACOGENETIC EPIDEMIOLOGICAL APPROACH TO BLADDER CANCERThe Lancet, 1982
- Acetanilide and paracetamol pharmacokinetics before and during phenytoin administration: genetic control of induction?British Journal of Clinical Pharmacology, 1981
- ARYL-HYDROCARBON-HYDROXYLASE INDUCIBILITY IN PATIENTS WITH CANCERThe Lancet, 1978
- The effects of chronic drug administration on hepatic enzyme induction and folate metabolism.British Journal of Clinical Pharmacology, 1978
- Paracetamol metabolism following overdosage: application of high performance liquid chromatographyJournal of Pharmacy and Pharmacology, 1977
- Enzyme induction by oral testosteroneClinical Pharmacology & Therapeutics, 1976
- Interactions between nutritional factors and drug biotransformations in man.Proceedings of the National Academy of Sciences, 1976
- Smoking and Cancer of the Lower Urinary TractNew England Journal of Medicine, 1971